<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01998334</url>
  </required_header>
  <id_info>
    <org_study_id>SAP BUNDLE-CRRT</org_study_id>
    <secondary_id>12411950500</secondary_id>
    <nct_id>NCT01998334</nct_id>
  </id_info>
  <brief_title>Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis</brief_title>
  <official_title>Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ruijin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic Inflammatory response syndrome(SIRS) is common in patients with severe acute
      pancreatitis (SAP) in early stage. Continuous Blood Purification (CBP), especially Continuous
      Veno-Venous Hemofiltration(CVVH) is proved to have an important role in SAP patients to
      control SIRS. But the detail treatment for this is controversial. In this study, the
      investigators aim to evaluate the different effects of three kinds of treatment protocols
      which is CVVH 6h,continuous venovenous hemodiafiltration(CVVHDF) 6h,CVVH 10h for first three
      days in SAP patients. Compare the vital sign, SIRS parameters, and others between these three
      groups. This study will try to find a better way for CBP in patients with SAP
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Condition Severe Acute Pancreatitis

      Intervention CVVH 6 hours for first three days CVVH 10 hours for first three days CVVHDF 6
      hours for first three days

      All therapeutic volume is 45ml/kg.h, Device: Braxter HF 1200
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Efficiency of CBP with Inflammatory Response</measure>
    <time_frame>3 days</time_frame>
    <description>Efficiency of CBP with inflammatory response was assessed by the following measurements:
Inflammatory mediators removal:tumor necrosis factor-α, interleukin(IL-1, IL-2, IL-6, and IL-8, IL-10, sIL-2R)before and after CBP in first three days
SIRS parameters variation: (Heart rate, respiratory rate, White Blood Cell, Temperature, C response protein) before and after CBP in first three days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality of 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operation time</measure>
    <time_frame>28 days</time_frame>
    <description>operation time of 28 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local complication of severe acute pancreatitis</measure>
    <time_frame>28 days</time_frame>
    <description>local complication of SAP in 28 days</description>
  </secondary_outcome>
  <other_outcome>
    <measure>ICU and hospital duration</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 8 weeks</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>CVVH 6h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CVVH 6h for first three days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CVVH 10h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CVVH 10h for first three days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CVVHDF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CVVHDF 6h for first three days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CVVH 6h</intervention_name>
    <description>CVVH 6h for first three days</description>
    <arm_group_label>CVVH 6h</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CVVH 10h</intervention_name>
    <description>CVVH 10h for first three days</description>
    <arm_group_label>CVVH 10h</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CVVHDF 6h</intervention_name>
    <description>CVVHDF 6h for first three days</description>
    <arm_group_label>CVVHDF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion Criteria:

          1. Diagnosis of pancreatitis:

               -  Typical pain

               -  Increase in serum lipase or amylase

               -  Onset of abdominal pain within &lt;=72h before admission

          2. The diagnosis criteria of Severe Acute Pancreatitis is according to Atlanta criteria
             revisited in 2012

          3. no chronic diseases such as Chronic Obstructive Pulmonary Disease, Diabetes Mellitus
             and so on

          4. Age from 18 to 65 years old

        Besides criteria above, the patient should also satisfied one of these CBP criteria:

          1. Have Acute Kidney Injury satisfied RIFLE classification (risk above): increased Serum
             Creatinine &gt; 1.5 times baseline，26.5umol/L increase, or urine output &lt; 0.5ml/kg.h for
             6 hours

          2. Systemic Inflammatory Response Syndrome: temperature &gt;38℃ or&lt;36℃；heart rate
             respiratory rate White blood cell count &gt;12*10^9/L，or&lt; 4*10^9/L

          3. Refractory acid-base and electrocyte balance disorder, metabolic acidosis conservative
             treatment is not effective.

        Exclusion Criteria:

          1. Pregnancy

          2. Chronic pancreatitis

          3. Immunosuppression condition such as HIV, Corticosteroid for 3 weeks in 60 days; White
             Blood Cell &lt; 0.5*10^9/L for 10 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enqiang Mao, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Department of EICU Ruijin Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of EICU, Ruijin Hospital,</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erzhen Chen, M.D</last_name>
      <phone>86-13901753478</phone>
    </contact>
    <contact_backup>
      <last_name>Enqiang Mao, M.D</last_name>
      <phone>13501747906</phone>
    </contact_backup>
    <investigator>
      <last_name>Jingyi Wu, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erzhen Chen, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2013</study_first_submitted>
  <study_first_submitted_qc>November 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>November 23, 2013</last_update_submitted>
  <last_update_submitted_qc>November 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruijin Hospital</investigator_affiliation>
    <investigator_full_name>Erzhen Chen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Systemic Inflammatory Response Syndrome</keyword>
  <keyword>Continuous Blood Purification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

